Early Life
Chung Yong-ji was born in South Korea on February 25, 1970. He earned a Bachelor of Science in Genetic Engineering from Sungkyunkwan University, a Master's degree in biology at the University of Texas at San Antonio, and a PhD in molecular biology (animal science) from Cornell University in 1996. He also conducted postdoctoral research in Breast Oncology at the Northwestern University Feinberg School of Medicine from 2000 to 2001.
Rise to Success
Chung founded Caregen in August 2001. Caregen went public on the KOSDAQ in 2015, raising approximately $160 million. As of late 2023, Chung holds roughly 64% of the company. The company is best known for its anti-wrinkle treatments and diabetes drugs.
Key Business Strategies
Caregen's success is built on peptide technology research and development. The company sells its products to more than 130 countries. Its most popular product is an injectable dermal filler that treats wrinkles. Another revenue source is Dr. CYJ Hair Filler, which claims to help regrow hair. Chung has signed a global exclusive agreement with BASF, a global chemical company, to supply cosmetic peptides and has focused on developing treatments for COVID-19, macular degeneration, and diabetes.
Philanthropy
Information regarding specific philanthropy amounts is unavailable in the search results. However, the Hyundai Group, which Chung's family has ties to, has a history of philanthropic initiatives, particularly through the Asan Foundation.
